Medtronic Plc Stock Fundamentals
| MDT Stock | USD 93.07 0.74 0.80% |
Medtronic PLC fundamentals help investors to digest information that contributes to Medtronic PLC's financial success or failures. It also enables traders to predict the movement of Medtronic Stock. The fundamental analysis module provides a way to measure Medtronic PLC's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Medtronic PLC stock.
At this time, Medtronic PLC's Total Operating Expenses is comparatively stable compared to the past year. Income Before Tax is likely to gain to about 5.8 B in 2025, whereas Net Income is likely to drop slightly above 2.2 B in 2025. Medtronic | Select Account or Indicator |
Medtronic PLC Company Return On Asset Analysis
Medtronic PLC's Return on Asset or ROA shows how effective is the management of the company in generating income from utilizing all of the assets at their disposal. It is a useful ratio to evaluate the performance of different departments of a company as well as to understand management performance over time.
Current Medtronic PLC Return On Asset | 0.0466 |
Most of Medtronic PLC's fundamental indicators, such as Return On Asset, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Medtronic PLC is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Return on Asset measures overall efficiency of a company in generating profits from its total assets. It is expressed as the percentage of profits earned per dollar of Asset. A low ROA typically means that a company is asset-intensive and therefore will needs more money to continue generating revenue in the future.
| Competition |
Medtronic Total Assets
Total Assets |
|
Based on the latest financial disclosure, Medtronic PLC has a Return On Asset of 0.0466. This is 100.53% lower than that of the Health Care Equipment & Supplies sector and 100.26% lower than that of the Health Care industry. The return on asset for all United States stocks is 133.29% lower than that of the firm.
Medtronic PLC Fundamental Drivers Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Medtronic PLC's current stock value. Our valuation model uses many indicators to compare Medtronic PLC value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Medtronic PLC competition to find correlations between indicators driving Medtronic PLC's intrinsic value. More Info.Medtronic PLC is rated below average in return on equity category among its peers. It also is rated below average in return on asset category among its peers reporting about 0.55 of Return On Asset per Return On Equity. The ratio of Return On Equity to Return On Asset for Medtronic PLC is roughly 1.81 . At this time, Medtronic PLC's Return On Equity is comparatively stable compared to the past year. Comparative valuation analysis is a catch-all technique that is used if you cannot value Medtronic PLC by discounting back its dividends or cash flows. It compares the stock's price multiples to nearest competition to determine if the stock is relatively undervalued or overvalued.Medtronic Return On Asset Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Medtronic PLC's direct or indirect competition against its Return On Asset to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Medtronic PLC could also be used in its relative valuation, which is a method of valuing Medtronic PLC by comparing valuation metrics of similar companies.Medtronic PLC is currently under evaluation in return on asset category among its peers.
Medtronic PLC ESG Sustainability
Some studies have found that companies with high sustainability scores are getting higher valuations than competitors with lower social-engagement activities. While most ESG disclosures are voluntary and do not directly affect the long term financial condition, Medtronic PLC's sustainability indicators can be used to identify proper investment strategies using environmental, social, and governance scores that are crucial to Medtronic PLC's managers, analysts, and investors.Environmental | Governance | Social |
Medtronic Fundamentals
| Return On Equity | 0.0844 | ||||
| Return On Asset | 0.0466 | ||||
| Profit Margin | 0.13 % | ||||
| Operating Margin | 0.22 % | ||||
| Current Valuation | 136.05 B | ||||
| Shares Outstanding | 1.28 B | ||||
| Shares Owned By Insiders | 0.26 % | ||||
| Shares Owned By Institutions | 86.16 % | ||||
| Number Of Shares Shorted | 13.49 M | ||||
| Price To Earning | 20.44 X | ||||
| Price To Book | 2.38 X | ||||
| Price To Sales | 3.57 X | ||||
| Revenue | 32.36 B | ||||
| Gross Profit | 21.78 B | ||||
| EBITDA | 8.2 B | ||||
| Net Income | 3.68 B | ||||
| Cash And Equivalents | 1.54 B | ||||
| Cash Per Share | 8.59 X | ||||
| Total Debt | 26.05 B | ||||
| Debt To Equity | 0.51 % | ||||
| Current Ratio | 1.76 X | ||||
| Book Value Per Share | 38.48 X | ||||
| Cash Flow From Operations | 6.79 B | ||||
| Short Ratio | 1.94 X | ||||
| Earnings Per Share | 3.28 X | ||||
| Price To Earnings To Growth | 1.86 X | ||||
| Target Price | 97.05 | ||||
| Number Of Employees | 95 K | ||||
| Beta | 0.82 | ||||
| Market Capitalization | 118.42 B | ||||
| Total Asset | 89.98 B | ||||
| Retained Earnings | 30.4 B | ||||
| Working Capital | 11.15 B | ||||
| Current Asset | 23.6 B | ||||
| Current Liabilities | 7.17 B | ||||
| Annual Yield | 0.03 % | ||||
| Five Year Return | 2.18 % | ||||
| Net Asset | 89.98 B | ||||
| Last Dividend Paid | 2.79 |
About Medtronic PLC Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Medtronic PLC's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Medtronic PLC using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Medtronic PLC based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.| Last Reported | Projected for Next Year | ||
| Current Deferred Revenue | 316.8 M | 301 M | |
| Total Revenue | 37.2 B | 39.1 B | |
| Cost Of Revenue | 12.9 B | 13.5 B | |
| Stock Based Compensation To Revenue | 0.01 | 0.01 | |
| Research And Ddevelopement To Revenue | 0.08 | 0.10 | |
| Capex To Revenue | 0.04 | 0.06 | |
| Revenue Per Share | 22.39 | 23.51 | |
| Ebit Per Revenue | 0.15 | 0.25 |
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for Medtronic Stock Analysis
When running Medtronic PLC's price analysis, check to measure Medtronic PLC's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Medtronic PLC is operating at the current time. Most of Medtronic PLC's value examination focuses on studying past and present price action to predict the probability of Medtronic PLC's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Medtronic PLC's price. Additionally, you may evaluate how the addition of Medtronic PLC to your portfolios can decrease your overall portfolio volatility.